Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GF Fermentech is a South Korean biotechnology company specializing in the production of high-value bioactive compounds through advanced microbial fermentation technologies. As a subsidiary of Genofocus, the company focuses on the development and commercialization of health-functional ingredients, most notably Vitamin K2 (Menaquinone-7) and high-molecular-weight Hyaluronic Acid. Their proprietary platform utilizes Bacillus subtilis and other microbial strains to produce natural, solvent-free ingredients for the pharmaceutical, nutraceutical, and cosmeceutical industries. GF Fermentech is recognized for its high-purity production capabilities and its commitment to sustainable bio-manufacturing processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GF Fermentech.